Syndax Pharmaceuticals (SNDX) Assets Average (2016 - 2025)
Historic Assets Average for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Q3 2025 value amounting to $574.0 million.
- Syndax Pharmaceuticals' Assets Average rose 2715.93% to $574.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $574.0 million, marking a year-over-year increase of 2715.93%. This contributed to the annual value of $668.8 million for FY2024, which is 2050.06% up from last year.
- Per Syndax Pharmaceuticals' latest filing, its Assets Average stood at $574.0 million for Q3 2025, which was up 2715.93% from $618.4 million recorded in Q2 2025.
- Syndax Pharmaceuticals' 5-year Assets Average high stood at $682.8 million for Q1 2025, and its period low was $251.3 million during Q3 2021.
- Its 5-year average for Assets Average is $455.5 million, with a median of $445.6 million in 2023.
- As far as peak fluctuations go, Syndax Pharmaceuticals' Assets Average skyrocketed by 24401.53% in 2021, and later soared by 754.32% in 2023.
- Syndax Pharmaceuticals' Assets Average (Quarter) stood at $344.6 million in 2021, then rose by 24.34% to $428.5 million in 2022, then increased by 18.11% to $506.1 million in 2023, then rose by 13.69% to $575.3 million in 2024, then dropped by 0.23% to $574.0 million in 2025.
- Its Assets Average stands at $574.0 million for Q3 2025, versus $618.4 million for Q2 2025 and $682.8 million for Q1 2025.